EU/3/19/2236
About
On 9 January 2020, orphan designation EU/3/19/2236 was granted by the European Commission to Consorcio Centro de Investigación Biomédica en Red, M.P, Spain, for dimethyl fumarate for the treatment of adrenoleukodystrophy.
Key facts
Active substance |
dimethyl fumarate
|
Disease / condition |
Treatment of adrenoleukodystrophy
|
Date of first decision |
09/01/2020
|
Outcome |
Positive
|
EU designation number |
EU/3/19/2236
|
Sponsor's contact details
Consorcio Centro de Investigación Biomédica en Red, M.P.
Pab 11
Avenida Monforte De Lemos 3-5
28029 Madrid
Spain
Tel: + 34 911 718 114
E-mail: gestores@ciberer.es
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.